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Detection and mapping of illicit 
drugs and their metabolites 
in ingermarks by MALDI MS 
and compatibility with forensic 
techniques
G. Groeneveld1,2,*, M. de Puit1,3,*, S. Bleay4, R. Bradshaw2 & S. Francese2
Despite the proven capabilities of Matrix Assisted Laser Desorption Ionisation Mass Spectrometry 
(MALDI MS) in laboratory settings, research is still needed to integrate this technique into current 
forensic ingerprinting practice. Optimised protocols enabling the compatible application of MALDI 
to developed ingermarks will allow additional intelligence to be gathered around a suspect’s lifestyle 
and activities prior to the deposition of their ingermarks while committing a crime. The detection 
and mapping of illicit drugs and metabolites in latent ingermarks would provide intelligence that 
is beneicial for both police investigations and court cases. This study investigated MALDI MS 
detection and mapping capabilities for a large range of drugs of abuse and their metabolites in 
ingermarks; the detection and mapping of a mixture of these drugs in marks, with and without 
prior development with cyanoacrylate fuming or Vacuum Metal Deposition, was also examined. Our 
indings indicate the versatility of MALDI technology and its ability to retrieve chemical intelligence 
either by detecting the compounds investigated or by using their ion signals to reconstruct 2D maps 
of ingermark ridge details.
Over the past seven years, Matrix Assisted Laser Desorption Ionisation Mass Spectrometry (MALDI 
MS) has proven to be a versatile analytical technology for gathering information (or intelligence) from 
latent ingermarks by detecting and mapping their chemistry1–4. However, despite a number of prom-
ising advances and its current evaluation in pseudo-operational trials in collaboration with the West 
Yorkshire Police (UK), much research is still needed to assess its full potential and the forensic sce-
narios in which this technology could be feasibly applied. Recent work undertaken on ingermarks 
deposited on a range of surfaces (porous and non-porous) has indicated varying degrees of MALDI 
MS compatibility with a number of forensic enhancement techniques (FET) conventionally used by 
Crime Scene Investigators (CSI) to visualise ingermarks, including aluminium and TiO2 powders, nin-
hydrin, 1,8-diazaluoren-9-one, cyanoacrylate Fuming (CAF) and Vacuum Metal Deposition (VMD)5. 
Compatibility ranged from the ability to detect molecular species ater development (including endoge-
nous species and some persistent chemicals present in toiletry products) to the opportunity to additionally 
map their distribution, thus providing multiple molecular images of the ingermark ridge pattern. Both 
levels of compatibility are of interest herein. he ability to image molecules in ingermarks using MALDI 
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MS Imaging (MALDI MSI) may provide additional physical information (ridge detail) to support suspect 
identiication6,7. Alternatively, following successful enhancement by a conventionally employed FET, the 
much faster MALDI MS Proiling (MALDI MSP) could be used to detect the chemistry of the marks to 
provide additional intelligence on the suspect’s lifestyle or actions prior to depositing the mark. In the 
aforementioned study5, VMD was the most compatible technique with MALDI MSI, most likely due to 
the reported ability of gold to act as a strong signal enhancer in mass spectrometry8. However, in these 
initial studies, attention was mainly focused on the detection and mapping of endogenous compounds. 
CAF on the other hand, although not the FET least compatible with MALDI, did not allow the retrieval 
of the same molecular species that were found following the application of VMD prior to MALDI MSI. 
herefore, both the CAF-MALDI and VMD-MALDI worklows need further investigation to make the 
technology operational. hese studies are particularly appropriate now, owing to the routine operational 
use of CAF and VMD and the recent interest from the scientiic community in their compatibility with 
other analytical spectroscopic and spectrometric techniques. In addition to the work done by Francese’s 
group, VMD has been examined in conjunction with another analytical technique to provide intelligence 
at a molecular level by Bailey’s group9. In particular, they recently reported the application of a number of 
FET, including VMD, followed by TOF SIMS. he focus of this paper was mainly on demonstrating the 
ability to obtain TOF SIMS (molecular) images of developed marks where conventional FET had failed. 
hough this was demonstrated for a number of FET, no data/images were shown for a VMD-TOF SIMS 
treated ingermark. Compatibility with CAF has received more attention9–11. In particular, Day et al.10 
considered a “handling” scenario and demonstrated the ability to detect a number of drugs in spiked 
ungroomed and CAF-developed ingermarks using Raman spectroscopy; the drugs investigated included 
codeine, cocaine, amphetamine, barbital and nitrazepam (as well as cafeine, aspirin, paracetamol, starch 
and talc, which can be used to adulterate drugs). Sundar and Rowell11 also considered a handling sce-
nario for two drugs of abuse, speciically cocaine and methadone, in ungroomed ingermarks (in addition 
to cafeine, aspirin, and paracetamol). In this study, both SALDI MS and MALDI MS were investigated 
separately, in combination with CAF. hough the MS experiments performed are not very informative, 
especially because of the lack of conirmatory MS/MS analysis, there were indications that cocaine and 
methadone could be detected in un-lited marks by both techniques. Moreover, the data suggested that 
only SALDI MS was successful in detecting these species in lited marks following the exposure of CAF 
marks to acetone vapours prior to mass spectrometric analysis. It is, however, diicult to establish the 
actual signiicance of the reported SALDI images for cocaine and methadone in the CAF-developed 
marks as the images were highly pixelated (no ridge detail), not normalised and had no colour scale.
As there is only one reported study using MALDI MS for the detection of (only) two illicit drugs in 
ingermarks11, the argument for a more comprehensive study that investigates a larger range of drugs, 
as well as their metabolites, in developed marks is compelling. Additionally, as this previous study11 
investigated these drugs only and in large amounts (1 mg), we wished to probe the sensitivity of MALDI 
technology by signiicantly lowering the amount of drug material. With respect to our previously pub-
lished research, this is the irst time that drugs and metabolites have been investigated by MALDI MSP 
and MSI as exogenous substances in undeveloped and pre-developed marks. his current research also 
provides insight into which drugs/metabolites are more amenable to MALDI MSI, particularly post-CAF 
and post-VMD development, as well as insight into the detection constraints and sensitivity limitations 
of the technology. Furthermore, this work has shed light on the most eicient FET-MALDI worklows 
(here FET refer to CAF and VMD). he latter point is very important and is the essence of all develop-
mental work being undertaken in our laboratory to ensure that MALDI is used operationally and does 
not remain an academic exercise.
For this study, 17 compounds (parent drugs and metabolites, including the methamphetamine and 
4-methylamphetamine isomers) were selected from 5 diferent classes of drug: amphetamines, alkaloids, 
opioids, cannabinoids and designer drugs. he inclusion of this number of species in these MALDI MS 
proiling and imaging analyses relects the importance of detecting forensically relevant substances such 
as drugs of abuse and their metabolites in pre-developed marks. Mapping such “story telling” substances 
directly onto the identifying ingerprint ridges will potentially generate circumstantial, associative or 
even corroborative evidence on the suspect’s lifestyle and activities, allowing more informed criminal 
investigations and judicial debates. Importantly, detecting drug metabolites would indicate drug “abuse” 
rather than “handling”, which pertain to two very diferent forensic scenarios.
his study initially established the “basics” and the potential of MALDI for the detection of drugs 
and their metabolites in ingermarks. For this purpose, the ionisation eiciency was initially optimised 
in both MS and MS/MS modes (the latter for a conirmatory test on the presence of the substance). 
he limits of detection (LOD) were subsequently investigated, which informed subsequent ingertip 
spiking experiments. Two scenarios were tested to mimic “handling” (drug concentrations of the order 
of 0.5 µ g of the pure compound contaminating the tip of a inger) and “abuse” (drug concentrations 
depended on the LOD obtained during preliminary studies and ranged from 0.05 to 0.0005 µ g of pure 
compound). However, in the latter case, the literature ofers no information on the possible amounts 
eventually retrievable in ingermarks. he only available studies refer to the quantitation of some of these 
species in sweat patches. For example, in a study by Barnes et al.12, the excretion of methamphetamine 
in sweat following consumption was demonstrated by GC-MS, with values ranging between 307 and 
53.8 ng/patch, although no metabolites were identiied. In another study by Barnes et al.13, the excretion 
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of 3,4-methylenedioxy-methamphetamine (MDMA) was investigated using GC-MS. hese analyses 
showed the presence of MDMA as the primary analyte, in concentrations up to 3007 ng/patch, and the 
formation of the methylenedioxyamphetamine (MDA) metabolite was detected in only 29.4% of the 
patches at a concentration lower than 172 ng/patch. A study by Kacinko et al.14 showed that following 
cocaine administration, cocaine was the primary analyte detected within sweat patches using GC-MS, 
with up to 375.4 ng/patch. Ecgonine methyl ester (EME) was detected more oten, with up to 35.9 ng/
patch, whereas benzoylecgonine (BZE) was recovered at levels up to 47 ng/patch. Kintz et al.15 showed 
that following heroin use, the intact drug is the primary analyte, with up to 96.3 ng/patch detected by 
GC-MS, though the primary metabolites of heroin, 6-monoacetylmorphine (6-MAM) and morphine, 
were also detected, with up to 24.6 and 11.2 ng/patch, respectively. Finally, as studied by Huestis 
et al.16, ∆ 9-tetrahydrocannabinol (THC, cannabis) is the primary compound observed in sweat patches, 
retrieved at a concentration of up to 3.85 ng/patch using GC-MS. hough the primary metabolite, THCA, 
was not observed, its detection was investigated here.
In the present study, to verify the possibility of retrieving and mapping drugs and their metabolites 
following the pre-development of drug-containing ungroomed ingermarks, marks were subjected to 
diferent types of CAF-MALDI, VMD-MALDI and CAF-VMD-MALDI worklows, with MALDI being 
employed in both proiling (MS and MS/MS) and imaging (MSI) modes. Findings from this study con-
irm previous observations indicating that VMD works much more compatibly with MALDI than CAF, 
with the ion signals appearing as strong or even stronger ater VMD development than ater no prior 
development. Within the CAF-MALDI worklow, the overall results indicate that although the drug 
signal intensity is much lower in many cases, as an efect of pre-development, intelligence can still be 
provided on the presence of these species. All drug and metabolite ion signals were conirmed through 
post-imaging MS/MS experiments, and on many occasions, they were also still intense enough to provide 
an image of the ridge detail. hese results represent a further step towards the implementation of MALDI 
technology in forensic casework.
Materials and Methods
All methods were carried out in accordance with the approved guidelines; speciically, methodologies 
and chemicals were risk assessed and approved by the Bioscience Technical Team (HWB Professional 
and Technical Services). he researcher performed the experiments using his own ingermarks, ater 
washing ingertips as previously reported1. No ethical approval was required for this work, as the pro-
cedure for ingermark use in these studies is considered minor by Sheield Hallam University Ethics 
Research Committee.
Materials. Acetone, acetonitrile (ACN), ethanol (EtOH) and methanol (MeOH) were purchased from 
Fisher Scientiic (Loughborough, UK). α -Cyano-4-hydroxycinnamic acid (α -CHCA) and triluoroacetic 
acid (TFA) were purchased from Sigma-Aldrich (Poole, UK). Amphetamine (speed, AMP), methylb-
enzoylecgonine (cocaine, COC), diacetylmorphine (heroin, HER), ∆ 9-tetrahydrocannabinol (cannabis, 
∆ 9-THC), 3,4-methylenedioxy-methamphetamine (ecstasy, MDMA), methylenedioxyamphetamine 
(MDA), ecgonine methyl ester (EME), benzoylecgonine (BZE), 6-acetylmorphine (6-MAM), morphine 
(MOR) and 11-nor-9-carboxy-THC (THCA) were purchased as analytical references from Cerilliant 
(Sigma-Aldrich, Zwijndrecht, he Netherlands). An illicit drug calibration mixture consisting of 2C-B, 
amphetamine, 4-methylamphetamine, methamphetamine, MDA, MDMA, MDEA, mCPP, cocaine, her-
oin and methadone was supplied by the Netherlands Forensic Institute, Department of Illicit Substances 
(he Hague, he Netherlands). MALDI target OPTI TOF spotless inserts were purchased from Applied 
Biosystems (Foster City, CA, USA). Double-sided conductive carbon tape was purchased from TAAB 
(Aldermaston, UK). ALUGRAM SIL G/UV254 pre-coated aluminium sheets were purchased from 
Boomlab (Meppel, Netherlands). Ethyl-2-cyanoacrylate for cyanoacrylate fuming was purchased from 
BVDA (Haarlem, he Netherlands).
Instrumentation and instrumental settings. All mass spectrometric analyses were conducted 
using a modiied Applied Biosystems “Q-Star” Pulsar i hybrid quadruple time-of-light (QqTOF) instru-
ment (Concord, Ontario, Canada). he “Q-Star” Pulsar i system consists of an orthogonal MALDI 
source that has been modiied to incorporate a SPOT 10 kHz Nd:YVO4 solid-state laser (Elforlight Ltd., 
Daventry, UK)17 with a wavelength of 355 nm and a pulse duration of 1.5 ns that produces an elliptical 
spot size of 100 × 150 µ m. MALDI MS spectra were obtained in positive ion mode in the mass range 
between m/z 50 and 1000. he declustering potential 2 was set at 15 arbitrary units (a.u.) and the focus 
potential at 10 a.u. with an accumulation time of 0.117 sec. MALDI MS/MS spectra were acquired ater 
setting the declustering potential 2 at 15 a.u., the focusing potential at 20 a.u., the collision gas (argon) 
at 2 a.u. with the collision energy ranging between 15 and 35 a.u., according to the drug being analysed. 
he collision gas pressure was set at 12 a.u. Mass spectra were processed either in Analyst MDS Sciex V2 
(Concord, Ontario, Canada) or converted to text iles and processed using the open source multifunc-
tional mass spectrometry sotware mMass18,19. Molecular images were acquired at a spatial resolution of 
150 × 150 µ m in raster mode using the oMALDI server 5.1 sotware supplied by MDS Sciex (Concord, 
Ontario, Canada) and processed using Biomap (Novartis, Basel, Switzerland). Cyanoacrylate fuming 
(CAF) was performed using a modiied glass ish-tank equipped with an IKA Ret heater/stirrer set at 
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120 °C as the heating source, an aluminium fuming cupboard and a mounting system to enclose the alu-
minium slides on which marks were deposited. Suitable humidity was achieved by heating an aluminium 
bowl containing dH2O prior to the fuming of ethylcyanoacrylate. A humidity sensor was employed to 
ensure that a relative humidity of ~80% was achieved. Vacuum metal deposition (VMD) was performed 
at the Home Oice Centre of Applied Science and Technology (CAST, UK) according to the procedure 
recommended by the Home Oice edited Fingermark Visualisation Manual20.
Drug/metabolite limit of detection (LOD), selectivity and conirmation of identity. he drug/
metabolite standard solutions were diluted to a concentration of 10 µ g/mL using MeOH and subse-
quently mixed thoroughly with 10 mg/mL α -CHCA in 70:30 v/v ACN:0.5% TFAaq at a ratio of 1:1. 
Aliquots of 0.5 µ L were spotted separately onto a previously cleaned aluminium plate and subsequently 
subjected to MALDI MS and MALDI MS/MS experiments.
For the determination of LOD, ungroomed ingermarks were prepared as reported previously1. On 
top of each mark, a serial dilution containing a mixture of compounds at ive pre-deined dilution levels 
was spotted. he standard mixtures studied were a) AMP, MDMA and MDA; b) COC, BZE and EME; 
c) HER, 6-MAM and MOR; and d) ∆ 9-THC and THCA. Every mixture was prepared in a range of 
compound concentrations: 10, 1, 0.1, 0.01 and 0.001 µ g/mL, thus preparing 5 concentration points for 
each of the mixtures (a–d). For every standard mixture, 0.5 µ L were spotted at ive separate locations (at 
diferent compound concentrations) across the length of the mark. Upon drying under ambient condi-
tions, the marks containing each of the 5 spots were spray-coated with 5 mg/mL α -CHCA in the 70:30 
v/v ACN:0.5% TFAaq matrix solution. Four layers of matrix were applied using the SunCollect auto-
spraying system (SunChrom GmbH, Friedrichsdorf, Germany) at a rate of 2 µ L/min employing “slow 
raster” settings. MALDI selectivity was assessed by analysing the complex mixtures containing 10 of the 
17 studied compounds. Spiked ungroomed ingermarks were prepared by mixing the parent drug and 
the metabolite either at “physiological ratios” (as indicated by the available literature) or in a 1:1 ratio. 
Speciically, cocaine, BZE and EME were used to spike a ingermark at a ratio of 5:1:1; the same ratio 
was used for heroin, 6-MAM and morphine. For this ratio, the amounts of each pure compound were 
2.5, 0.5 and 0.5 µ g, respectively; for amphetamine/MDA and THC/THCA, a ratio of 1:1 was employed 
with 2.5 µ g-amounts of the pure compounds.
MS/MS analyses were employed (with no further treatment of the mark) in addition to MS analy-
ses, and the acquisition parameters were optimised to conirm the presence and identity of the species 
through the recovery of molecular weight and structural information. hese analyses were applied to the 
pure standards and to the spiked ingermarks in post-imaging acquisition.
Preparation of spiked latent ingermarks with exogenous compounds: “handling” versus 
“abuse” scenarios. Ungroomed ingertips were prepared as previously described1. Aliquots (50 µ L) of 
a 10 µ g/mL stock solution of the illicit drug/metabolite of interest (equivalent to 0.5 µ g of pure compound 
for each standard) were applied to a pre-cleaned glass microscope slide (high concentration = “handling 
scenario”). he solvent was allowed to evaporate under ambient conditions prior to extensively drag-
ging the ingertip side to side onto the glass slide to transfer as much analyte as possible. he ingertip 
was subsequently contacted with a pre-cleaned aluminium sheet, producing a drug-spiked, ungroomed 
ingermark. In addition, a further set of ungroomed marks was generated by spiking the ingertip in 
the same manner with a 50-µ L aliquot of the compound of interest at a concentration equivalent to the 
previously determined limit of detection (low concentration = “abuse scenario”).
Compatibility studies: FET-MALDI MSI worklow. Six replicates of ungroomed ingermarks 
enriched with drugs of abuse were prepared. Each ingermark was then spiked with a mixture of illicit 
drugs containing (i) AMP, (ii) COC, (iii) HER and (iv) ∆ 9-THC. Fingermarks deposited on aluminium 
slides were produced ater spiking ingertips using a 50-µ L aliquot of a 25-µ g/mL standard solution 
(equivalent to 1.25 µ g of pure compound) of this mixture using the previously described method. he 
marks were subsequently cut in half (to produce ‘split marks’). One half was let undeveloped, and the 
other was developed using (i) CAF, (ii) CAF followed by exposure of the mark to acetone vapours, (iii) 
CAF followed by Basic Yellow 40 dye-staining, (iv) VMD, (v) CAF followed by VMD or (vi) CAF fol-
lowed by Basic Yellow 40 dye-staining followed by VMD. he undeveloped and developed split marks 
were reassembled together on a MALDI target plate to form a full ingermark sample before being 
sprayed with matrix solution (5 mg/mL α -CHCA 70:30 v/v ACN:0.5% TFAaq, 4 layers at 2 µ L/min) and 
subjected to MALDI MSI analysis. For CAF (i), 0.25 g of ethyl-2-cyanoacrylate were heated at 120 °C in 
an aluminium cup at approximately 65–80% relative humidity using an in-house developed fuming cab-
inet containing a heating source and an aluminium bowl illed with water. he samples were suspended 
in the cabinet and developed within 5–10 minutes. In a separate experiment, CAF-developed marks were 
also exposed to acetone vapours (ii); speciically, acetone (0.5 mL) was placed into an aluminium fuming 
cupboard and heated at 50 °C (near the boiling point of acetone). Additional Basic Yellow 40 dye-staining 
of CAF-developed marks (iii) was performed as follows: the CAF-developed half mark was sprayed with 
a Basic Yellow 40 (BY40) working solution (2 g/L in EtOH). Excess Basic Yellow 40 staining solution was 
washed away using deionised H2O, and the mark was allowed to dry under ambient conditions. VMD 
(iv) was performed at CAST (Home Oice, St Albans, UK). For VMD worklows, split marks were either 
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subjected to VMD and then to MALDI (iv) or preliminarily developed with either CAF or CAF followed 
by Basic Yellow 40 dye-staining prior to VMD enhancement at CAST (samples (v) and (vi), respectively). 
Images of all developed half marks were captured using a VSC4CX videospectral comparator (Foster and 
Freeman, Evesham, UK) under visible light.
Results and Discussion
As this is the irst time that the detection and mapping of a vast range of illicit drugs and metabolites 
in ingermarks have been investigated by MALDI in a sequential worklow with forensic enhancement 
techniques (FET), the MS and MS/MS conditions were initially optimised. MALDI MS and MALDI 
MS/MS spectra were acquired in positive mode for 17 compounds, and optimised instrumental condi-
tions were subsequently established. As shown in Table  1 and Fig. S1, all compounds were detectable 
as [M+ H]+ ions in MS mode and generated characteristic ion fragment signatures in MS/MS mode. 
Furthermore, to provide insight into the speciicity of MALDI detection, a mixture of ten compounds 
(5-dimethoxy-4-bromophenethylamine (2-CB), amphetamine, 4-methylamphetamine, methampheta-
mine, 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), 
meta-chlorophenylpiperazine (mCPP), cocaine, heroin and methadone) was analysed by MALDI MS. 
Drug
MALDI–QTOF–MS MALDI-QTOF-MS/MS MALDI-QTOF-MSI
Observed [M+ H]+ & IS fragment
Diference 
(amu)*
m/z precursor 
→ productions** Ref
LOD 
ng/µ L
LOD*** 
ng/cm2
#Handling 
ng/cm2
#Abuse 
ng/cm2
Amphetamine C9H13N C9H13N 136.1371 [M+ H]
+ 91.0751 [ISF] –0.0245 136 → 119, 91 [24] 10 2,96 189.5 18,95
4–MeAmph C10H15N 150.1315 [M+ H]
+ –0.0032 150 → 133, 105, 91 [24] − − − − 
MethAmph C10H15N 150.1315 [M+ H]
+ –0.0032 150 → 119, 91 [24,25] − − − − 
MDMA C11H15NO2 194.1458 [M+ H]
+ 163.1017 [ISF] –0.0277
194 → 163, 
135,105,58
[24,25] 1 0,88 189.5 18,95
MDA C10H13NO2 180.1367 [M+ H]
+ 163.1015 [ISF] –0.0343
180 → 163, 
135,105,72
[24,25] 1 0,88 189.5
MDEA C12H17NO2 208.1664 [M+ H]
+ 182.1474 [ISF] –0.0327
208 → 163, 135, 
105, 72
[24,26] − − − − 
Cocaine C17H21NO4 304.1907 [M+ H]
+ 182.1474[ISF] –0.0359
304 → 272, 182, 
150, 82
[24,26] 0,01 0,0088 189.5 0.19
BZE C16H19NO4 290.1708 [M+ H]
+ 168.1270 [ISF] –0.0316
290 → 272, 168, 
150,82
[24,26] 0,1 0,088 189.5 1,895
EME C10H17NO3 200.1548 [M+ H]
+ 182.1495 [ISF] –0.0262
200 → 182, 168, 
150,82
[26] 0,1 0,088 189.5 1,895
Methadone C21H27NO 310.2474 [M+ H]
+ 265.1706 [ISF] –0.0303
310 → 265, 247, 
223,159,105
[24] − − − − 
Heroin C21H23NO5 370.1841 [M+ H]
+ 310.1846 [ISF] –0.0187
370 → 328, 310, 
286,211,193
[24,27] 0,1 0,088 189.5 1,895
6–MAM C19H21NO4 328.1948 [M+ H]
+ 268.1733 [ISF] –0.0400
328 → 310, 286, 
211,193,165
[24,27] 0,1 0,088 189.5 1,895
Morphine C17H19NO3 286.1737 [M+ H]
+ –0.0294
286 → 268, 211, 
193,165
[24,27] 0,1 0,088 189.5 1,895
THC C21H30O2 315.2712 [M+ H]
+ –0.0389
315 → 315, 300, 
259,193,135,123
[24] 10 2,96 189.5 1,895
THCA C21H28O4 345.2463 [M+ H]
+ –0.0397
345 → 327, 299, 
257,229,193
[24] 10 2,96 189.5 1,895
2 CB C10H14
79BrNO2 260.0612 0.0326 [28] − − − − 
C10H14
81BrNO2 262.0647 0.0381
262 → 245, 230, 
164
mCPP C10H13ClN2 197.0926 [M+ H]
+ –0.0075
197 → 181, 154, 
119,91
[28] − − − − 
Table 1.  List of the m/z values detected for drugs, their metabolites and their associated ion fragments 
via MS and MS/MS as well as the limits of detection observed in the two MALDI imaging experiments 
(spotted drug and high/low concentration spiking). he table also reports MS/MS conditions and the 
literature references supporting structural conirmation and molecular identiication. *Calculated diference 
between measured m/z and calculated monoisotopic [M+ H]+. **MS/MS product ions obtained for 
structure elucidation, supported by previous studies. ***ng/cm2 as determined by dividing the amount of 
drug (volume/concentration) over the area of the applied spot (cm2) as shown in (see Fig. 3). #ng/cm2 as 
determined by dividing the amount of drug (pure amount) over the area of a ingermark (~2.64 cm2) (see 
Fig. 4).
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All ten species were detected, with no signiicant ion suppression impeding detection of any one species 
(Fig.  1). Although 4-methylamphetamine and methamphetamine, being isomers, have the same m/z, 
they were diferentiated by MS/MS because of the diference in their fragmentation patterns, as Fig. S1 
illustrates. In the MS analyses performed under optimised conditions, most compounds also exhibited 
the formation of in-source fragments (spontaneous fragmentation in the ion source of the mass spec-
trometer). In contrast for all other compound classes screened, in-source fragments of the amphetamine 
class showed a higher abundance than that of the corresponding molecular ion [M+ H]+. In-source 
fragments can be a valuable signature for the rapid and more reliable identiication of the drug/metab-
olite present in ingermarks, although MS/MS is always recommended; in fact, MS/MS data have been 
used throughout this study as a reference to deinitively conirm the presence of the species of interest.
In subsequent experiments, ingertips were spiked with both the parent drug and its metabolites in 
either an approximate “physiological” ratio based on data from the available literature14,15, as for cocaine 
and its metabolites as well as heroin and its metabolites, or in an arbitrary 1:1 ratio, as for amphetamine/
MDA and THC/THCA, to provide information on any potential ion suppression by the parent drug or 
the metabolite when using MALDI MSI. he molecular image of cocaine shows better ridge continuity 
than that obtained for BZE, though ridge detail can be fully obtained for the latter (Fig. 2). Conversely, 
EME did not show full ridge detail but rather a dot-like distribution. he molecular images of metabolites 
6-MAM and morphine were slightly poorer than the one obtained for heroin, though they still provided 
ridge detail. Within these two classes of analytes, no evidence of ion suppression was found, but the 
higher concentration of the parent drug certainly improves the quality of the corresponding molecular 
images. MALDI MSI of 1:1 dual spiked marks of AMP/MDA and THC/THCA allowed for the detection 
and mapping of the species, but the quality of the images was very poor for THC and THCA. he poor 
THC/THCA image quality was observed previously in analyses in which these species were investigated 
separately; thus, it cannot be directly ascribed to the simultaneous presence of both species. Post-imaging 
MS/MS analyses were used to conirm the presence of all species investigated. All of these data show 
good drug screening capabilities in ingermarks containing multiple drugs (in a single analysis) as well 
as the capability to detect and map both the parent drug and its metabolites.
Prior to the FET-MALDI worklow experiments, the limits of detection for MALDI had been estab-
lished for a range of drugs/metabolites by investigating ingermarks spotted with serial dilutions of these 
compounds ranging from 10 to 0.001 µ g/µ L. Five spots of the drug/metabolite mixtures from each drug 
class were deposited across the length of the mark in a serial dilution. he mark was then spray coated 
with matrix and subjected to MALDI MSI analysis. he LOD recovered here refers to the concentration 
Figure 1. MALDI-QTOF-MS spectrum of a solution containing 10 illicit drugs at a concentration of 
10 µg/mL mixed with an equal volume of matrix solution. Using the predominant [M+ H]+ parent ions 
formed, the compounds can be identiied based on MS and MS/MS experiments. Methamphetamine and 
4-methylamphetamine were not diferentiated in MS mode owing to mass-to-charge overlap (m/z 150.1).
www.nature.com/scientificreports/
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of drug/metabolite in the spot corresponding to the lowest dilution that could be observed in the pro-
cessed molecular images of the compound of interest, and these values are reported in Table 1. As shown 
in Fig. 3 and Table 1, the LOD is strongly class and compound dependent, which is due to diferences 
in their ionisation eiciencies. he amphetamine and cannabinoid classes show the lowest ionisation 
eiciencies with drugs and metabolites and could provide spot images at only the highest concentration 
tested (10 µ g/mL). Alkaloid detection in spot images ranged from 10 ng/ml to 10 µ g/mL, whereas the 
LOD for opioids was between 100 and 10 ng/mL. Further processing of the data by brightness-saturation 
of the images showed molecular images of some species in additional spots (Fig. S2). For example, MDA/
MDMA were also visible at 1 µ g/mL, and EME, heroin, 6-MAM and morphine were visible at 100 ng/mL. 
Notably, in all cases illustrated in Figs  3 and S2, it may be possible to obtain molecular maps of the 
drugs at concentrations between that corresponding to the last visible spot and that of the irst spot not 
detected; however, this intermediate concentration will have to be determined. Additionally, in some 
cases, even if the spot was not visible as an image, the ion signal in the corresponding extracted spectrum 
was still detectable, though conirmatory MS/MS experiments were not performed. With these types of 
MALDI MSI experiments, the amount of each compound is spread within a deined circular area (the 
spot). herefore, it is more appropriate to report LOD as a function of the amount of drug divided by 
its occupied area. By doing this, the observed LOD for visible spots was achieved as low as 0.009 ng/cm2.
Further “sensitivity” experiments were conducted that took the data from previous LOD determina-
tions into account. “Handling” and “abuse” scenarios were investigated by entirely spiking ingertips with 
either “high” (0.5 µ g) or “low” drug/metabolite amounts (ranging from 0.0005 to 0.05 µ g, respectively) 
prior to analysis by MALDI MSI. In similar studies investigating the detection of drugs in ingermarks, 
powder and/or tablets were used to transfer the drug onto the ingertip10,21. he amount transferred onto 
the ingertip or the amount of powder was not indicated in these studies; however, from the description, 
it can be speculated that milligram(s) amounts were transferred as a result of pure powder handling. 
herefore, speciically transferring between 0.0005 and 0.5 µ g of the drug/metabolite is a better approach 
for testing the sensitivity of the technology. Fingertips were spiked with ten selected drugs/metabolites 
individually (one compound per ingermark). Findings from this experiment are illustrated in Fig. 4. For 
the “handling” scenario in particular, the intensities of both parent ion and in-source fragments (when 
available) were high enough to generate molecular images of the compounds investigated, allowing 
reconstruction of the ingermark ridge pattern with second-level detail (minutiae) and grading from 1–4 
according to the 0–4 scale22. For MDA and THC, partial ingermark images could be obtained, whereas 
no images were recovered for THCA; this relects that the ionisation eiciency of this compound is lower 
Figure 2. MALDI MS images of ingermarks simultaneously spiked with drugs and their metabolites at 
deined ratios to show the distribution of samples containing (A) cocaine, BZE and EME in a 5:1:1 ratio; 
(B) heroin, 6-MAM, morphine in a 5:1:1 ratio; (C) amphetamine and MDA in a 1:1 ratio; and (D) THC and 
THCA in a 1:1 ratio.
www.nature.com/scientificreports/
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than that of the other drugs investigated, as previously observed (Fig. 3). he ion signals from the drugs 
of interest show comparable (cocaine, EME, 6-MAM, morphine) or even better (BZE, heroin) images of 
the ridge pattern compared to the best image obtained from an endogenous compound, which is merely 
shown as a comparison (and therefore its identity is unimportant). In the “abuse” scenario, cocaine, BZE 
and heroin could be suitably mapped on the ridges, whereas partial and or discontinuous ridge detail 
was obtained for EME and 6-MAM. No images were recovered for morphine, MDA, THC and THCA, 
Figure 3. MALDI MSI of serial dilutions ranging from 10 µg/mL to 1 ng/mL of the diferent drug 
classes (drug/metabolites) spotted on top of a ingermark and subsequently spray-coated. LODs were 
determined from (A) the amphetamine mixture, (B) the cocaine mixture, (C) the heroin mixture and (D) 
the THC mixture. he ion signals of the compounds are shown as an overlay (green) on top of the ion 
signal originating from an endogenous species (red) depicting the ridge pattern.
www.nature.com/scientificreports/
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Figure 4. MALDI MS images of ‘high’ (“handling” scenario) and ‘low’ (“abuse” scenario) spiked 
ingermarks contaminated with amphetamine, cocaine, BZE, EME, heroin, 6-MAM, morphine, MDA, 
THC and THCA. All images were normalised against the matrix peak at m/z 190. 
www.nature.com/scientificreports/
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and little was visible for the in-source AMP fragments. It is possible to determine the amount of drug 
per area within the ingermark as both the concentration and the volume of the exogenous compound 
are known. Overall, within the “handling” scenario, MALDI MSI of a ~190 ng/cm2 ingermark results in 
chemical images depicting the pattern of the mark, including second level detail or showing the distri-
bution of the drug/metabolite within the mark. Within the “abuse” scenario, the MALDI drug/metabolite 
molecular images generally depict a speckled ridge pattern, with the exception of cocaine, BZE, EME 
and heroin (albeit with diferent grades of ridge coverage). For these species, ingermark images could 
be retrieved at low concentrations of 0.19 (cocaine) and ~1.9 ng/cm2 (BZE, EME, heroin). For both the 
“handling” and the “abuse” scenarios, partial images could still be important. First, if a previously applied 
FET provides a good image for suspect ID and MALDI compatibility is proven, intelligence could still 
be provided by conirming the presence of these substances. Furthermore, partial images could still be 
superimposed onto the molecular images of other species present in the mark (such as endogenous 
ones) to demonstrate association of the drug/metabolite with the ridges of the suspect. Importantly, for 
full, partial or no ingermark molecular images, post-imaging MS and MS/MS proiling revealed and 
conirmed the presence of all investigated compounds (data not shown). Table 1 presents a summary of 
the MS and MS/MS detection of the drugs as well as the LODs calculated in ng/cm2 for the two types of 
imaging experiments performed (spotted marks and spiked marks within the “handling”/“abuse” scenar-
ios). Notably, for the “abuse” scenario, the real excreted quantity that might be present in ingermarks is 
not known, but a study in which the authors have recently participated indicated the ability of MALDI 
MSP to detect BZE in ingermarks from patients in a drug rehabilitation clinic at levels corresponding 
to < 16 ng/mL in oral luids23.
Information retrieved through conirmatory and LOD studies enabled the subsequent design of 
experiments to investigate the MALDI detection and mapping of a mixture of amphetamine, cocaine, 
heroin and THC in marks (a total of 1.25 µ g spread across the mark area) that were developed with 
CAF and/or VMD prior to MALDI MSI using diferent worklows. Speciically, two sets of experiments 
were performed on split ingermarks, and in all experiment sets, one half of the mark remained unde-
veloped and was directly subjected to MALDI MSI as a reference sample. In experiment set A, spiked 
half marks were subjected to 3 types of CAF enhancement prior to MALDI MSI analysis: (i) CAF, (ii) 
CAF + acetone vapour exposure and (iii) CAF + BY40 staining. hese types of enhancements followed 
by MALDI MSI were selected to determine which conditions allowed recovery of ridge detail and ion 
signals. Treatment with acetone following CAF was evaluated as it was recently reported to enhance the 
recovery of cocaine and methadone due to the partial dissolution of the CAF polymer11. Staining with 
BY40 following CAF was selected as this is the process oten used in crime labs and is recommended to 
Figure 5. MALDI MS images of split ingermarks spiked with a mixture of 4 drugs and analysed with 
and without prior FET development. All images were normalised to total ion current, but each entire 
ingermark image was adjusted to optimal brightness and contrast. A: MALDI MS images acquired ater 
CAF, CAF + acetone vapour exposure and CAF + BY40 staining. he last row of the panel shows the 
brightness increased to reveal enhanced 2D maps of cocaine, heroin and cholesterol. B: MALDI MS images 
acquired ater VMD, VMD + CAF and CAF + BY40 staining + VMD. For both panels A and B, the last row 
of the panels shows brightness increased to reveal enhanced 2D maps of cocaine, heroin and cholesterol.
www.nature.com/scientificreports/
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improve ridge enhancement in the CAST manual20. Molecular maps of the 4 drugs and cholesterol (the 
latter as an example endogenous compound recovery) are reported in Fig. 5A. Overall results corrobo-
rate previous observations regarding the ionisation eiciency of amphetamine and THC, which yielded 
the poorest molecular images. Amphetamine molecular maps were highly speckled both in the absence 
and presence of CAF development, although the ion signal appeared to be stronger in the undeveloped 
half of the mark. Treatment with acetone did not improve the quality of the image and BY40 staining 
did not yield any image. THC provided better ridge detail in one of the three undeveloped mark halves, 
but no image was obtained for the split mark analysed with condition (iii). Because the same image was 
theoretically expected for all of the undeveloped halves, the THC molecular maps lacked reproducibility, 
most likely due to the very low eiciency of ionisation of the compound and the strong dependence on 
the quality of the matrix co-crystallisation. Further investigations into diferent matrix systems and/or 
the employment of negative ionisation are needed, particularly for THC. Moreover, for THC, acetone 
treatment did not improve the quality of the image. Given that no THC image was obtained for the 
undeveloped half, it is not possible to comment on the efect of BY40, though image improvement is not 
expected. Cocaine and heroin behaved very similar to one another, as it was possible to obtain images 
for both undeveloped and developed marks under all conditions tested. In particular, though full ridge 
detail could be obtained following CAF and CAF-acetone development, sharper contours were observed 
for the corresponding undeveloped ingermark halves. BY40 had a marked efect on the intensity of the 
cocaine and heroin signals as faint ridge details were obtained for the CAF-BY40 treated ingermark 
halves compared to the untreated ones. However, it must be considered that brightness of the overall 
mark image was adjusted primarily to neatly observe the ridge detail in the undeveloped half; thus, a 
marked increase in the brightness shows that ridge detail was recoverable for cocaine, heroin and endog-
enous cholesterol also ater BY40 staining (last row of Fig.  5A). he endogenous cholesterol behaved 
in the same manner as cocaine and heroin within the three worklows analysed. he worsening of the 
molecular maps following BY40 staining may be due to a) strong absorption of the dye in the UV region, 
leaving little laser energy for the analytes present in the mark and b) depletion of the species of interest 
following immersion of the mark in stain and subsequent washing of the excess stain with deionised 
water. In addition, in all cases where a poor image or no image was obtained, post-imaging MS and MS/
MS analysis revealed and conirmed the presence of the drug of abuse. hese post-imaging analyses show 
the opportunity to provide intelligence on the presence of these substances, which can be very helpful, 
especially if CAF yielded a suitable ridge pattern image. Furthermore, these analyses show that MALDI 
is only a partially destructive process as the chemistry of the mark (and the ridge detail) can still be 
interrogated. Generally, though in our experiments the acetone treatment post-CAF development did 
not seem to yield an improvement in the detection of the ion signals, which is diferent than previously 
reported11, it was possible to obtain a ingermark ridge pattern image for cocaine (in addition to heroin 
and cholesterol). his shows that acetone post treatment is not required for the detection of these drugs 
under the experimental and instrumental conditions described in this paper.
In experiment set B, detection and mapping of the same four drugs and endogenous species by 
MALDI was investigated ater the following enhancement scenarios: (i) VMD, (ii) CAF + VMD and (iii) 
CAF + BY40 staining + VMD. Interestingly, in the majority of cases, the application of VMD boosted 
the ion signal, as relected by stronger MALDI images compared to the corresponding undeveloped 
marks (Fig. 5B), which corroborates previous observations5. he comparison between undeveloped and 
VMD-developed marks shows that amphetamine, cocaine, THC and cholesterol provide more intense 
molecular images ater VMD development, whereas heroin appears to yield an equally strong image. 
In this scenario, satisfactory ridge detail was obtained for only cholesterol and heroin, whereas cocaine 
yielded a grade 2 image, which is more useful than that provided by the VMD optical image in this 
instance (over-developed, most likely due to the use of fresh ingermarks). Under enhancement scenario 
(ii), all species, including amphetamine and THC, provide a suitable signal accompanied by ridge detail 
in the undeveloped half of the mark. he enhancement of the other half of the ingermark by CAF fol-
lowed by VMD also yields a robust signal, which is stronger for cocaine and heroin. his enhancement 
afected the mapping of amphetamine, THC and cholesterol, as their images showed scarce ridge detail. 
Finally, under scenario (iii), all species exhibited very strong signals again, providing excellent ridge 
detail in the undeveloped halves of the mark. he corresponding ingermark halves treated with CAF 
followed by BY40 staining and VMD yielded less intense signals and reduced ridge continuity. However, 
in this case, an increase in brightness, to the point of over-saturating the image of the undeveloped half 
of the mark, showed usable ridge detail generated by mapping of cocaine, heroin and endogenous cho-
lesterol. As with experiment set A, in set B, the presence and identity of the species were conirmed by 
post-imaging MS and MS/MS analyses.
Conclusions
For the irst time, MALDI proiling (MS and MS/MS) and imaging (in MS mode) protocols for the 
detection, conirmation, and mapping of a large range of drugs and their metabolites in ingermarks, as 
well as for determining the limits of detection (sensitivity), have been investigated and optimised. his 
work was aimed at furthering knowledge regarding the compatibility of MALDI with currently used 
forensic enhancement techniques (FET), in particular with cyanoacrylate fuming (CAF) and Vacuum 
Metal Deposition (VMD). Prior chemical treatment of the marks was generally expected to have an 
www.nature.com/scientificreports/
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efect on the ability of MALDI to yield the desired ion signal and corresponding 2D visualisation within 
the mark5,8 (as was also observed in this work). Nonetheless, we have shown here that prior application 
of FET does not prevent the detection of forensically interesting species, such as illicit drugs and their 
metabolites. Furthermore, molecular maps were retrieved ater CAF and VMD enhancement. Treatment 
with acetone following CAF did not improve the ion signal; however, in contrast to work published by 
others, 2D maps depicting the presence of cocaine on the mark ridges were nevertheless obtained. In 
the present study, it was observed that although the quality of the ridge pattern was strongly molecule 
dependent, VMD treatment appeared to be much more compatible than CAF, conirming the general 
ability of gold to enhance the MALDI signal. Although more work is needed to extend these studies to 
additional drugs and metabolites in “natural” ingermarks (e.g., those obtained with no prior ingertip 
cleaning or grooming procedure) deposited on a range of CAF and VMD amenable surfaces, the data 
presented here conirm the strong potential for implementing MALDI technology within the ingermark 
enhancement and chemical mapping worklows routinely used in forensic casework.
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